AZUR-1
What it tests: Clinical complete response with dostarlimab monotherapy in dMMR/MSI-H locally advanced rectal cancer (first results, registrational trial)
The week in oncology, in your inbox
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.